Valuation: Pathkey.AI Ltd

Market Cap 8.19Cr 5.87Cr 5.03Cr 4.7Cr 4.31Cr 8.08Cr 561.64Cr 56Cr 22Cr 282.14Cr 22Cr 22Cr 933.2Cr P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 8.19Cr 5.87Cr 5.03Cr 4.7Cr 4.31Cr 8.08Cr 561.47Cr 56Cr 22Cr 282.05Cr 22Cr 22Cr 932.92Cr EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day-5.56%
1 week-10.53%
Current month+17.24%
1 month-10.53%
3 months-12.82%
6 months+21.43%
Current year+112.50%
1 week 0.03
Extreme 0.034
0.04
1 month 0.03
Extreme 0.027
0.04
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
-5.56%-10.53%+47.83%-29.17% 3.29Cr
-1.05%+1.70%-14.77%+32.38% 4.03TCr
-6.99%+7.12%-37.47%+163.44% 1.43TCr
-1.35%-1.84%-21.60%+60.88% 565.62Cr
+6.30%+18.23%+70.58% - 432.59Cr
+0.81%+3.07% - - 206.9Cr
+0.23%-4.61%+5.83%-38.24% 162.3Cr
-3.58%+22.15%-29.55% - 118.18Cr
+9.22%+11.56%+45.13%+154.15% 103.08Cr
+2.88%-2.05%+49.48%+58.81% 102.76Cr
Average +0.09%+4.51%+12.83%+57.46% 715.65Cr
Weighted average by Cap. -1.58%+3.84%-12.60%+64.85%

Financials

2024 2025
Net sales 4L 3L 2L 2L 2L 4L 2.73Cr 26.99L 10.53L 1.37Cr 10.7L 10.47L 4.53Cr 3L 2L 2L 2L 2L 3L 2.21Cr 21.86L 9L 1.11Cr 9L 8L 3.67Cr
Net income -31.3L -22.44L -19.22L -17.98L -16.46L -30.9L -21Cr -2.12Cr -82.86L -11Cr -84.25L -82.42L -36Cr -14.48L -10.38L -9L -8L -8L -14.29L -9.93Cr -98.27L -38.32L -4.99Cr -38.97L -38.12L -16Cr
Net Debt -4L -3L -2L -2L -2L -4L -2.57Cr -25.43L -10L -1.29Cr -10.08L -10L -4.27Cr -25.17T -18.04T -15.45T -14.46T -13.23T -24.84T -17.26L -2L -66.61T -9L -67.73T -66.26T -28.68L
Logo Pathkey.AI Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
21/26/21 A$0.0340 -5.56% 59,91,746
20/26/20 A$0.0360 0.00% 34,73,592
19/26/19 A$0.0360 -5.26% 34,34,709
18/26/18 A$0.0380 -2.56% 33,61,561
17/26/17 A$0.0390 +2.63% 96,17,378